Premium
Changing prevalence of diabetes mellitus in bullous pemphigoid: it is the dipeptidyl peptidase‐4 inhibitors
Author(s) -
Gravani A.,
Gaitanis G.,
Tsironi T.,
Tigas S.,
Bassukas I.D.
Publication year - 2018
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.14957
Subject(s) - medicine , bullous pemphigoid , dipeptidyl peptidase 4 , diabetes mellitus , pemphigoid , dipeptidyl peptidase 4 inhibitor , dermatology , type 2 diabetes mellitus , endocrinology , immunology , type 2 diabetes , antibody